BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 12859253)

  • 1. Inhibition of human ornithine decarboxylase activity by enantiomers of difluoromethylornithine.
    Qu N; Ignatenko NA; Yamauchi P; Stringer DE; Levenson C; Shannon P; Perrin S; Gerner EW
    Biochem J; 2003 Oct; 375(Pt 2):465-70. PubMed ID: 12859253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-difluoromethylornithine (DFMO) as a potent arginase activity inhibitor in human colon carcinoma cells.
    Selamnia M; Mayeur C; Robert V; Blachier F
    Biochem Pharmacol; 1998 Apr; 55(8):1241-5. PubMed ID: 9719479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport.
    Samal K; Zhao P; Kendzicky A; Yco LP; McClung H; Gerner E; Burns M; Bachmann AS; Sholler G
    Int J Cancer; 2013 Sep; 133(6):1323-33. PubMed ID: 23457004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of polyamine biosynthesis in Crithidia fasciculata by D,L-alpha-difluoromethylornithine and D,L-alpha-difluoromethylarginine.
    Hunter KJ; Strobos CA; Fairlamb AH
    Mol Biochem Parasitol; 1991 May; 46(1):35-43. PubMed ID: 1852175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-difluoromethylornithine resistance in Leishmania donovani is associated with increased ornithine decarboxylase activity.
    Coons T; Hanson S; Bitonti AJ; McCann PP; Ullman B
    Mol Biochem Parasitol; 1990 Feb; 39(1):77-89. PubMed ID: 2154691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-difluoromethylornithine-resistant cell lines obtained after one-step selection of Leishmania mexicana promastigote cultures.
    Sánchez CP; Mucci J; González NS; Ochoa A; Zakin MM; Algranati ID
    Biochem J; 1997 Jun; 324 ( Pt 3)(Pt 3):847-53. PubMed ID: 9210409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ornithine decarboxylase along the mouse and rat nephron.
    Levillain O; Hus-Citharel A
    Am J Physiol; 1998 Jun; 274(6):F1020-8. PubMed ID: 9841492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revival of 2-(difluoromethyl)ornithine (DFMO), an inhibitor of polyamine biosynthesis, as a cancer chemopreventive agent.
    Raul F
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):353-5. PubMed ID: 17371277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of alpha-difluoromethylornithine resistant Leishmania donovani and its susceptibility to other inhibitors of the polyamine biosynthetic pathway.
    Mukhopadhyay R; Kapoor P; Madhubala R
    Pharmacol Res; 1996; 34(1-2):43-6. PubMed ID: 8981555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to D,L-alpha-difluoromethylornithine.
    Iten M; Mett H; Evans A; Enyaru JC; Brun R; Kaminsky R
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1922-5. PubMed ID: 9303385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyamine content of Pneumocystis carinii and response to the ornithine decarboxylase inhibitor DL-alpha-difluoromethylornithine.
    Merali S; Clarkson AB
    Antimicrob Agents Chemother; 1996 Apr; 40(4):973-8. PubMed ID: 8849262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison and characterization of growth inhibition in L1210 cells by alpha-difluoromethylornithine, an inhibitor of ornithine decarboxylase, and N1,N8-bis(ethyl)spermidine, an apparent regulator of the enzyme.
    Porter CW; Ganis B; Vinson T; Marton LJ; Kramer DL; Bergeron RJ
    Cancer Res; 1986 Dec; 46(12 Pt 1):6279-85. PubMed ID: 3096560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the ototoxicity of difluoromethylornithine and its enantiomers.
    McWilliams ML; Chen GD; Fechter LD
    Toxicol Sci; 2000 Jul; 56(1):124-32. PubMed ID: 10869460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of tumor burden on ornithine decarboxylase activity in mice.
    Saydjari R; Alexander RW; Upp JR; Poston GJ; Barranco SC; Townsend CM; Thompson JC
    Cancer Invest; 1991; 9(4):415-9. PubMed ID: 1884248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable ornithine decarboxylase in a rat hepatoma cell line selected for resistance to alpha-difluoromethylornithine.
    Mitchell JL; Hoff JA; Bareyal-Leyser A
    Arch Biochem Biophys; 1991 Oct; 290(1):143-52. PubMed ID: 1898085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized phase I chemoprevention dose-seeking study of alpha-difluoromethylornithine.
    Love RR; Carbone PP; Verma AK; Gilmore D; Carey P; Tutsch KD; Pomplun M; Wilding G
    J Natl Cancer Inst; 1993 May; 85(9):732-7. PubMed ID: 8478959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo inhibition of polyamine biosynthesis and growth in tobacco ovary tissues.
    Slocum RD; Galston AW
    Plant Cell Physiol; 1985; 26(8):1519-26. PubMed ID: 11539696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical changes associated with alpha-difluoromethylornithine uptake and resistance in Trypanosoma brucei.
    Bellofatto V; Fairlamb AH; Henderson GB; Cross GA
    Mol Biochem Parasitol; 1987 Oct; 25(3):227-38. PubMed ID: 3122042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanosoma cruzi as a model system to study the expression of exogenous genes coding for polyamine biosynthetic enzymes. Induction of DFMO resistance in transgenic parasites.
    Carrillo C; González NS; Algranati ID
    Biochim Biophys Acta; 2007 Dec; 1770(12):1605-11. PubMed ID: 17920200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ornithine decarboxylase activity in rabbit retina following treatment with alpha-difluoromethylornithine.
    Wong CG; Naripthaphan P; Renardel de Lavalette V
    Biochem Pharmacol; 1987 Dec; 36(24):4325-9. PubMed ID: 3120737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.